Takato Hiranita Selected Research

mitragynine

1/2022	In vitro and in vivo pharmacology of kratom.
1/2022	The Lack of Contribution of 7-Hydroxymitragynine to the Antinociceptive Effects of Mitragynine in Mice: A Pharmacokinetic and Pharmacodynamic Study.
1/2020	Investigation of the Adrenergic and Opioid Binding Affinities, Metabolic Stability, Plasma Protein Binding Properties, and Functional Effects of Selected Indole-Based Kratom Alkaloids.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takato Hiranita Research Topics

Disease

5	Pain (Aches) 01/2022 - 10/2020
5	Substance-Related Disorders (Drug Abuse) 01/2017 - 08/2004
4	Opioid-Related Disorders (Opiate Addiction) 01/2022 - 09/2019
3	Cocaine-Related Disorders (Cocaine Addiction) 01/2014 - 11/2011
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 12/2020 - 11/2014
1	Hypothermia 01/2022
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2022
1	Tremor (Tremors) 01/2022
1	Hypercapnia 09/2021
1	Respiratory Insufficiency (Respiratory Failure) 09/2021
1	Opiate Overdose 09/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2020
1	Mental Disorders (Mental Disorder) 03/2013
1	Cognitive Dysfunction 01/2010
1	Fasciculation (Fasciculations) 10/2008
1	Schizophrenia (Dementia Praecox) 10/2008

Drug/Important Bio-Agent (IBA)

4	Opioid Analgesics (Opioids)IBA 01/2022 - 10/2020
4	Pharmaceutical PreparationsIBA 08/2021 - 12/2004
3	mitragynineIBA 01/2022 - 01/2020
3	Cocaine (Cocaine HCl)IBA 01/2017 - 02/2013
2	LigandsIBA 01/2022 - 01/2017
2	CannabinoidsIBA 01/2022 - 01/2010
2	Proteins (Proteins, Gene)FDA Link 03/2013 - 10/2008
1	1-pentyl-3-(1-naphthoyl)indoleIBA 01/2022
1	5-F-ADB-PINACAIBA 01/2022
1	N- (1- amino- 3- methyl- 1- oxobutan- 2- yl)- 1- (5- fluoropentyl)- 1H- indazole- 3- carboxamideIBA 01/2022
1	RimonabantIBA 01/2022
1	OpiumIBA 01/2022
1	mu Opioid Receptors (mu Opioid Receptor)IBA 01/2022
1	Fentanyl (Sublimaze)FDA LinkGeneric 09/2021
1	Methylphenidate (Ritalin)FDA LinkGeneric 12/2020
1	Therapeutic UsesIBA 12/2020
1	Dextroamphetamine (Dexedrine)FDA LinkGeneric 12/2020
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2020
1	Analgesics (Analgesic Drugs)IBA 09/2019
1	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2017
1	Dopamine Uptake Inhibitors (Dopamine Reuptake Inhibitors)IBA 01/2014
1	rimcazoleIBA 11/2011
1	Dopamine (Intropin)FDA LinkGeneric 02/2011
1	2- (4- morpholino)ethyl- 1- phenylcyclohexane- 1- carboxylateIBA 02/2011
1	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 01/2010
1	Cyclooxygenase InhibitorsIBA 08/2004
1	EndocannabinoidsIBA 08/2004

Therapy/Procedure

1	Self Administration (Administration, Self) 02/2013